Found: 28
Select item for more details and to access through your institution.
Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 19, p. 5839, doi. 10.1002/ange.201600190
- By:
- Publication type:
- Article
Biological Evaluation of Valeriana Extracts from Argentina with Potent Cholinesterase Inhibition for the Treatment of Neurodegenerative Disorders and Their Comorbidities—The Case of Valeriana carnosa Sm. (Caprifoliaceae) Studied in Mice.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 129, doi. 10.3390/ph16010129
- By:
- Publication type:
- Article
Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1484, doi. 10.3390/ph15121484
- By:
- Publication type:
- Article
Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 19, p. 5745, doi. 10.1002/anie.201600190
- By:
- Publication type:
- Article
Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1784, doi. 10.3390/ijms23031784
- By:
- Publication type:
- Article
Synthesis of Indoline‐Based Benzhydroxamic Acids as Potential HDAC6 Inhibitors.
- Published in:
- ChemistrySelect, 2019, v. 4, n. 42, p. 12308, doi. 10.1002/slct.201902042
- By:
- Publication type:
- Article
Repurposing of 8‐Hydroxyquinoline‐Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors.
- Published in:
- ChemMedChem, 2022, v. 17, n. 5, p. 1, doi. 10.1002/cmdc.202100694
- By:
- Publication type:
- Article
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL BENZYLAMINE DERIVATIVES WITH HYDROXYETHYLAMINE PHARMACOPHORIC MOIETY AS MULTIFUNCTIONAL COMPOUNDS TARGETING CHOLINESTERASE, BETA-SECRETASE AND BETA-AMYLOID AGGREGATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P280, doi. 10.1016/j.jalz.2017.06.171
- By:
- Publication type:
- Article
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
- Published in:
- Scientific Reports, 2016, p. 39495, doi. 10.1038/srep39495
- By:
- Publication type:
- Article
Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones.
- Published in:
- ChemPhysChem, 2024, v. 25, n. 1, p. 1, doi. 10.1002/cphc.202300596
- By:
- Publication type:
- Article
BUTYRYLCHOLINESTERASE INHIBITORS GRAFTED WITH ANTIOXIDANT AND NEUROPROTECTIVE ACTIVITIES: NOVEL MULTIFUNCTIONAL LIGANDS FOR ALZHEIMER'S DISEASE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 127
- By:
- Publication type:
- Article
MOLECULAR MODELING IN SEARCH OF NEW, MULTI-TARGET LIGANDS AGAINST ALZHEIMER'S DISEASE. EXPLORING THE BIOCHEMICAL MULTIVERSE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 75
- By:
- Publication type:
- Article
FROM SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS TO MULTI-TARGET-DIRECTED LIGANDS AS LEAD COMPOUNDS FOR ALZHEIMER'S DISEASE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 70
- By:
- Publication type:
- Article
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 4, p. 505, doi. 10.1007/s11307-021-01584-2
- By:
- Publication type:
- Article
Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments.
- Published in:
- ChemBioChem, 2021, v. 22, n. 4, p. 743, doi. 10.1002/cbic.202000700
- By:
- Publication type:
- Article
N -Hydroxy- N -Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases.
- Published in:
- Molecules, 2022, v. 27, n. 21, p. 7437, doi. 10.3390/molecules27217437
- By:
- Publication type:
- Article
Screening of Big Pharma's Library against Various in-house Biological Targets.
- Published in:
- Molecules, 2022, v. 27, n. 14, p. N.PAG, doi. 10.3390/molecules27144484
- By:
- Publication type:
- Article
Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 1, p. 1, doi. 10.1007/s00018-021-04117-w
- By:
- Publication type:
- Article
WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
- Published in:
- Journal of Computer-Aided Molecular Design, 2021, v. 35, n. 2, p. 223, doi. 10.1007/s10822-020-00371-5
- By:
- Publication type:
- Article
Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment.
- Published in:
- Antioxidants, 2022, v. 11, n. 9, p. 1735, doi. 10.3390/antiox11091735
- By:
- Publication type:
- Article
Synthesis and preliminary biological evaluations of (+)-isocampholenic acid-derived amides.
- Published in:
- Molecular Diversity, 2016, v. 20, n. 3, p. 667, doi. 10.1007/s11030-016-9668-9
- By:
- Publication type:
- Article
Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3431, doi. 10.3390/cells10123431
- By:
- Publication type:
- Article
Synthesis and Cholinesterase Inhibitory Activity of Selected Indole-Based Compounds.
- Published in:
- Acta Chimica Slovenica, 2023, v. 70, n. 4, p. 545, doi. 10.17344/acsi.2023.8460
- By:
- Publication type:
- Article
4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B.
- Published in:
- Molecules, 2021, v. 26, n. 14, p. 4118, doi. 10.3390/molecules26144118
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease.
- Published in:
- Molecules, 2016, v. 21, n. 5, p. 634, doi. 10.3390/molecules21050634
- By:
- Publication type:
- Article
Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta.
- Published in:
- Molecules, 2016, v. 21, n. 4, p. 410, doi. 10.3390/molecules21040410
- By:
- Publication type:
- Article
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease.
- Published in:
- Theranostics, 2021, v. 11, n. 13, p. 6542, doi. 10.7150/thno.54589
- By:
- Publication type:
- Article
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ<sub>1−42</sub> Aggregation Inhibitors for Alzheimer's Disease Therapy.
- Published in:
- ChemMedChem, 2016, v. 11, n. 12, p. 1318, doi. 10.1002/cmdc.201500539
- By:
- Publication type:
- Article